Article
Pharmacogenomics and epilepsy: the road ahead.
Pharmacogenomics - 1 Oct 2011
Cavalleri Gianpiero L, McCormack Mark, Alhusaini Saud, Chaila Elijah, Delanty Norman
Abstract excerpt
Epilepsy is one of the most common, serious neurological disorders, affecting an estimated 50 million people worldwide. The condition is typically treated using antiepileptic drugs of which there are 16 in widespread use. However, there are many different syndrome and seizure types within epilepsy and information guiding clinicians on the most effective drug and dose for individual patients is lacking. Further,...
Topics
- Alleles
- Anticonvulsants
- Biomarkers, Pharmacological
- Epilepsy
- Genome-Wide Association Study
- Humans
- Pharmacogenetics
- Polymorphism, Single Nucleotide